Molecule Details
| InChIKey | BTVPMDAMCUGYJV-UHFFFAOYSA-N |
|---|---|
| Compound Name | N-[2,4-difluoro-3-[4-[3-(1-prop-2-enoylpyrrolidin-3-yl)oxy-1H-pyrazolo[5,4-b]pyridin-5-yl]triazol-1-yl]phenyl]-3-phenylbenzenesulfonamide |
| Canonical SMILES | C=CC(=O)N1CCC(Oc2n[nH]c3ncc(-c4cn(-c5c(F)ccc(NS(=O)(=O)c6cccc(-c7ccccc7)c6)c5F)nn4)cc23)C1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.55 |
| Source | ChEMBL |
2D Structure
Activity Profile
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| Q9NYL2 | MAP3K20 | Homo sapiens | Human | PF07714 PF07647 | 7.9 | IC50 | ChEMBL |
| P53667 | LIMK1 | Homo sapiens | Human | PF00412 PF00595 PF07714 | 7.9 | IC50 | ChEMBL |
| P53671 | LIMK2 | Homo sapiens | Human | PF00412 PF00595 PF07714 | 7.7 | IC50 | ChEMBL |
| P06239 | LCK | Homo sapiens | Human | PF07714 PF00017 PF00018 | 6.7 | IC50 | ChEMBL |